Actively Recruiting
Dengvaxia US Pregnancy Registry
Led by Sanofi Pasteur, a Sanofi Company · Updated on 2026-01-21
500
Participants Needed
1
Research Sites
338 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy
CONDITIONS
Official Title
Dengvaxia US Pregnancy Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women of any age residing in the US or its Territories
- Women with Dengvaxia vaccine exposure during pregnancy reported to the pregnancy registry
- Reports containing sufficient evidence confirming exposure during pregnancy
- Vaccine name provided, including cases with unknown manufacturer
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Investigational Site
San Juan, Puerto Rico
Actively Recruiting
Research Team
D
Dengvaxia US Pregnancy Registry HelpLine
CONTACT
T
Trial Transparency email recommended (Toll free number for US & Canada)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here